These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 3955904

  • 1. The natural history of IgA nephritis in Singapore.
    Woo KT, Edmondson RP, Wu AY, Chiang GS, Pwee HS, Lim CH.
    Clin Nephrol; 1986 Jan; 25(1):15-21. PubMed ID: 3955904
    [Abstract] [Full Text] [Related]

  • 2. Factors predicting progression of IgA nephropathies.
    Coppo R, D'Amico G.
    J Nephrol; 2005 Jan; 18(5):503-12. PubMed ID: 16299675
    [Abstract] [Full Text] [Related]

  • 3. IgA nephropathy: analysis of the natural history, important factors in the progression of renal disease, and a review of the literature.
    Ibels LS, Györy AZ.
    Medicine (Baltimore); 1994 Mar; 73(2):79-102. PubMed ID: 8152367
    [Abstract] [Full Text] [Related]

  • 4. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
    Lv J, Zhang H, Zhou Y, Li G, Zou W, Wang H.
    Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
    [Abstract] [Full Text] [Related]

  • 5. The significance of focal and segmental hyalinosis and sclerosis (FSHS) and nephrotic range proteinuria in IgA nephropathy.
    Packham DK, Yan HD, Hewitson TD, Nicholls KM, Fairley KF, Kincaid-Smith P, Becker GJ.
    Clin Nephrol; 1996 Oct; 46(4):225-9. PubMed ID: 8905206
    [Abstract] [Full Text] [Related]

  • 6. Prognostic factors in immunoglobulin-A nephropathy.
    Muthukumar T, Fernando ME, Jayakumar M.
    J Assoc Physicians India; 2002 Nov; 50():1354-9. PubMed ID: 12583461
    [Abstract] [Full Text] [Related]

  • 7. Glomerulonephritis in Singapore: an overview.
    Woo KT, Chiang GS, Edmondson RP, Wu AY, Lee EJ, Pwee HS, Lim CH.
    Ann Acad Med Singap; 1986 Jan; 15(1):20-31. PubMed ID: 3707031
    [Abstract] [Full Text] [Related]

  • 8. Clinical features and natural history of IgA nephropathy.
    Rychlik I, Andrassy K, Waldherr R, Zuna I, Tesar V, Jancová E, Stejskalová A, Ritz E.
    Ann Med Interne (Paris); 1999 Feb; 150(2):117-26. PubMed ID: 10392260
    [Abstract] [Full Text] [Related]

  • 9. The "point of no return" and the rate of progression in the natural history of IgA nephritis.
    Schöll U, Wastl U, Risler T, Braun N, Grabensee B, Heering P, Schollmeyer P, Zäuner I, Stein G, Fünfstück R, Keller F.
    Clin Nephrol; 1999 Nov; 52(5):285-92. PubMed ID: 10584991
    [Abstract] [Full Text] [Related]

  • 10. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
    Shen K, Yu Y, Tang Z, Liu Z, Li L.
    Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
    [Abstract] [Full Text] [Related]

  • 11. IgA nephropathy in patients over 50 years of age: a multicentre, prospective study.
    Frimat L, Hestin D, Aymard B, Mayeux D, Renoult E, Kessler M.
    Nephrol Dial Transplant; 1996 Jun; 11(6):1043-7. PubMed ID: 8671966
    [Abstract] [Full Text] [Related]

  • 12. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study.
    Manno C, Strippoli GF, D'Altri C, Torres D, Rossini M, Schena FP.
    Am J Kidney Dis; 2007 Jun; 49(6):763-75. PubMed ID: 17533019
    [Abstract] [Full Text] [Related]

  • 13. Histological grading of IgA nephropathy predicting renal outcome: revisiting H. S. Lee's glomerular grading system.
    Lee HS, Lee MS, Lee SM, Lee SY, Lee ES, Lee EY, Park SY, Han JS, Kim S, Lee JS.
    Nephrol Dial Transplant; 2005 Feb; 20(2):342-8. PubMed ID: 15618239
    [Abstract] [Full Text] [Related]

  • 14. [Clinical course and prognostic factors in lupus nephropathy].
    Gamba G, Quintanilla L, del Bosque MD, Chew-Wong A, Correa-Rotter R.
    Rev Invest Clin; 2000 Feb; 52(4):397-405. PubMed ID: 11061101
    [Abstract] [Full Text] [Related]

  • 15. Predictors of outcome in Henoch-Schönlein nephritis in children and adults.
    Coppo R, Andrulli S, Amore A, Gianoglio B, Conti G, Peruzzi L, Locatelli F, Cagnoli L.
    Am J Kidney Dis; 2006 Jun; 47(6):993-1003. PubMed ID: 16731294
    [Abstract] [Full Text] [Related]

  • 16. "Point of no return (PNR)" in progressive IgA nephropathy: significance of blood pressure and proteinuria management up to PNR.
    Komatsu H, Fujimoto S, Sato Y, Hara S, Yamada K, Morita S, Eto T.
    J Nephrol; 2005 Jun; 18(6):690-5. PubMed ID: 16358226
    [Abstract] [Full Text] [Related]

  • 17. Natural history of primary IgA nephropathy.
    Berthoux FC, Mohey H, Afiani A.
    Semin Nephrol; 2008 Jan; 28(1):4-9. PubMed ID: 18222341
    [Abstract] [Full Text] [Related]

  • 18. Presentation, prognosis and outcome of IgA nephropathy in Indian adults.
    Chacko B, John GT, Neelakantan N, Korula A, Balakrishnan N, Kirubakaran MG, Jacob CK.
    Nephrology (Carlton); 2005 Oct; 10(5):496-503. PubMed ID: 16221102
    [Abstract] [Full Text] [Related]

  • 19. Can immunosuppressive drugs slow the progression of IgA nephropathy?
    Goumenos D, Ahuja M, Shortland JR, Brown CB.
    Nephrol Dial Transplant; 1995 Oct; 10(7):1173-81. PubMed ID: 7478120
    [Abstract] [Full Text] [Related]

  • 20. Focal segmental glomerulosclerosis is not a sufficient predictor of renal outcome in patients with membranous nephropathy.
    Heeringa SF, Branten AJ, Deegens JK, Steenbergen E, Wetzels JF.
    Nephrol Dial Transplant; 2007 Aug; 22(8):2201-7. PubMed ID: 17442739
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.